{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:56Z","timestamp":1793726516964,"version":"4.6.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","award":["CRP\/ NGA18-02"],"award-info":[{"award-number":["CRP\/ NGA18-02"]}],"id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council","award":["MRC_UU_00028\/6"],"award-info":[{"award-number":["MRC_UU_00028\/6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) is a multifactorial neurodegenerative disorder driven by genetic predisposition and environmental exposure. Given its well-documented antioxidative and neuroprotective properties, resveratrol is increasingly being considered for its potential to counteract the neuronal damage characteristic of Parkinson\u2019s disease. Here, we investigated the therapeutic action of resveratrol in a transgenic\n                    <jats:italic>Drosophila melanogaster<\/jats:italic>\n                    model expressing human \u03b1-synuclein (\n                    <jats:italic>SNCA<\/jats:italic>\n                    , PD flies), in combination with network pharmacology and molecular docking analyses. The PD flies were fed diet supplemented with resveratrol (15, 30, and 60\u00a0mg\/kg diet, approximately 6.57, 13.14 and 26.28\u00a0mM, respectively), to evaluate lifespan. This was followed by a 21-day treatment of PD flies with similar concentrations of resveratrol in the diet to evaluate cognitive function, oxidative stress, and antioxidant biomarkers, using Levodopa\u00a0(0.1 mM) as positive control. The results showed that resveratrol supplementation in the diet significantly improved lifespan, locomotor activity, acetylcholinesterase and catalase activities, and thiol content compared to untreated PD flies. Furthermore, resveratrol reduced nitric oxide (nitrite\/nitrate), malondialdehyde, and total hydroperoxide levels, and enhanced cellular metabolic activity and upregulated\n                    <jats:italic>Sod1<\/jats:italic>\n                    mRNA expression (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). The network pharmacology and molecular docking analyses identified key molecular targets that may account for the therapeutic action of resveratrol, including B-Cell Lymphoma 2, Monoamine Oxidase (MAO); in flies, MAO-Like, Dopa Decarboxylase, Protein Kinase A and Glycogen Synthase Kinase-3\u00a0(GSK-3). Among these, MAO and GSK-3 emerged as top targets as indicated by network prominence and strong binding interactions. Additionally, the binding interaction of resveratrol to SNCA at specific sites suggests a potential role in inhibiting its aggregation, which is a hallmark of PD pathology. Quantum mechanics calculations revealed that resveratrol functions as both a proton donor and acceptor, contributing to its strong target binding interactions and antioxidant potential. Overall, resveratrol supplementation in the diet may be beneficial for PD management by modulating dopamine metabolism, apoptosis, oxidative stress, and cell survival. The study provides valuable experimental and computational insights into the underlying therapeutic mechanisms of action of resveratrol and supports its potential use in PD management.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-00698-9","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:31:16Z","timestamp":1747888276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Experimental and computational insights into the therapeutic mechanisms of resveratrol in a Drosophila \u03b1-synuclein model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Amos Olalekan","family":"Abolaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeola Oluwatosin","family":"Adedara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Chizoba","family":"Madu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwabunmi Tomilola","family":"Owalude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oludare Michael","family":"Ogunyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damilola A.","family":"Omoboyowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folorunsho Bright","family":"Omage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"698_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101695","volume":"37","author":"VS Van Laar","year":"2020","unstructured":"Van Laar, V. S. et al. \u03b1-synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo. Redox Biol. 37, 101695 (2020).","journal-title":"Redox Biol."},{"key":"698_CR3","first-page":"1","volume":"52","author":"ZB Kaya","year":"2021","unstructured":"Kaya, Z. B. & Atilla, P. An overview of alpha synuclein protein and its role in Parkinson\u2019s disease. Acta Med. 52, 1\u201310 (2021).","journal-title":"Acta Med."},{"key":"698_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","volume":"33","author":"LL Venda","year":"2010","unstructured":"Venda, L. L., Cragg, S. J., Buchman, V. L. & Wade-Martins, R. \u03b1-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease. Trends Neurosci. 33, 559\u2013568 (2010).","journal-title":"Trends Neurosci."},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","volume":"30","author":"DA Scott","year":"2010","unstructured":"Scott, D. A. et al. A pathologic cascade leading to synaptic dysfunction in \u03b1-synuclein-induced neurodegeneration. J. Neurosci. 30, 8083\u20138095 (2010).","journal-title":"J. Neurosci."},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1074\/jbc.M000206200","volume":"275","author":"JM Souza","year":"2000","unstructured":"Souza, J. M., Giasson, B. I., Chen, Q., Lee, V.M.-Y. & Ischiropoulos, H. Dityrosine cross-linking promotes formation of stable \u03b1-synuclein polymers: Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275, 18344\u201318349 (2000).","journal-title":"J. Biol. Chem."},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20150617","volume":"471","author":"A Gustot","year":"2015","unstructured":"Gustot, A. et al. Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease. Biochem. J. 471, 323\u2013333 (2015).","journal-title":"Biochem. J."},{"key":"698_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"P Dion\u00edsio","year":"2021","unstructured":"Dion\u00edsio, P., Amaral, J. & Rodrigues, C. Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Res. Rev. 67, 101263 (2021).","journal-title":"Ageing Res. Rev."},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2015.02.020","volume":"274","author":"R Vanhauwaert","year":"2015","unstructured":"Vanhauwaert, R. & Verstreken, P. Flies with Parkinson\u2019s disease. Exp. Neurol. 274, 42\u201351 (2015).","journal-title":"Exp. Neurol."},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.4238\/2012.May.21.6","volume":"116","author":"A Todd","year":"2012","unstructured":"Todd, A. & Staveley, B. E. Expression of Pink1 with \u03b1-synuclein in the dopaminergic neurons of Drosophila leads to increases in both lifespan and healthspan. Genet. Mol. Res. 116, 1497\u20131502 (2012).","journal-title":"Genet. Mol. Res."},{"key":"698_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1073\/pnas.0610204104","volume":"104","author":"CR Scherzer","year":"2007","unstructured":"Scherzer, C. R. et al. Molecular markers of early Parkinson\u2019s disease based on gene expression in blood. Proc. Natl. Acad. Sci. 104, 955\u2013960 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"698_CR12","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1002\/med.21718","volume":"40","author":"D Li","year":"2020","unstructured":"Li, D., Mastaglia, F. L., Fletcher, S. & Wilton, S. D. Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson\u2019s disease in the precision medicine era. Med. Res. Rev. 40, 2650\u20132681 (2020).","journal-title":"Med. Res. Rev."},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/hmg\/ddu520","volume":"24","author":"S Gispert","year":"2015","unstructured":"Gispert, S. et al. Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression. Hum. Mol. Genet. 24, 1061\u20131076 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"698_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-021-00208-2","volume":"22","author":"S Ganesan","year":"2021","unstructured":"Ganesan, S. & Parvathi, V. D. Deconstructing the molecular genetics behind the PINK1\/Parkin axis in Parkinson\u2019s disease using Drosophila melanogaster as a model organism. Egypt. J. Med. Hum. Genet. 22, 1\u201320 (2021).","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"698_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnbeh.2016.00121","volume":"10","author":"D Ferrazzoli","year":"2016","unstructured":"Ferrazzoli, D. et al. Dopamine replacement therapy, learning and reward prediction in Parkinson\u2019s disease: Implications for rehabilitation. Front. Behav. Neurosci. 10, 121 (2016).","journal-title":"Front. Behav. Neurosci."},{"key":"698_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"M Delgado-Alvarado","year":"2016","unstructured":"Delgado-Alvarado, M., Gago, B., Navalpotro-Gomez, I., Jim\u00e9nez-Urbieta, H. & Rodriguez-Oroz, M. C. Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease. Mov. Disord. 31, 861\u2013881 (2016).","journal-title":"Mov. Disord."},{"key":"698_CR17","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.3390\/ijms20205220","volume":"20","author":"P-S Huang","year":"2019","unstructured":"Huang, P.-S., Wang, C.-S., Yeh, C.-T. & Lin, K.-H. Roles of thyroid hormone-associated microRNAs affecting oxidative stress in human hepatocellular carcinoma. Int. J. Mol. Sci. 20, 5220 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"698_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3945\/an.114.007500","volume":"6","author":"I Solanki","year":"2015","unstructured":"Solanki, I., Parihar, P., Mansuri, M. L. & Parihar, M. S. Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv. Nutr. 6, 64\u201372 (2015).","journal-title":"Adv. Nutr."},{"key":"698_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.plaphy.2019.09.039","volume":"144","author":"M Olszowy","year":"2019","unstructured":"Olszowy, M. What is responsible for antioxidant properties of polyphenolic compounds from plants?. Plant Physiol. Biochem. 144, 135\u2013143 (2019).","journal-title":"Plant Physiol. Biochem."},{"key":"698_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111259","volume":"189","author":"A Vaiserman","year":"2020","unstructured":"Vaiserman, A., Koliada, A. & Lushchak, O. Neuroinflammation in pathogenesis of Alzheimer\u2019s disease: Phytochemicals as potential therapeutics. Mech. Ageing Dev. 189, 111259 (2020).","journal-title":"Mech. Ageing Dev."},{"key":"698_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.21608\/aps.2021.92639.1068","volume":"5","author":"KA Mohamad","year":"2021","unstructured":"Mohamad, K. A., Wahdan, S. A. & Elnaga, R. N. Overview on Parkinson\u2019s disease: Pathophysiology, and experimental models. Arch. Pharm. Sci. Ain Shams Univ. 5, 212\u2013224. https:\/\/doi.org\/10.21608\/aps.2021.92639.1068 (2021).","journal-title":"Arch. Pharm. Sci. Ain Shams Univ."},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s42269-023-01047-4","volume":"47","author":"A Sayyaed","year":"2023","unstructured":"Sayyaed, A., Saraswat, N., Vyawahare, N. & Kulkarni, A. A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson\u2019s disease with insights into screening models. Bull. Natl. Res. Centre 47, 70. https:\/\/doi.org\/10.1186\/s42269-023-01047-4 (2023).","journal-title":"Bull. Natl. Res. Centre"},{"key":"698_CR23","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1038\/s41598-024-58877-z","volume":"14","author":"A Vikhar Danish Ahmad","year":"2024","unstructured":"Vikhar Danish Ahmad, A., Khan, S. W., Ali, S. A. & Yasar, Q. Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety. Sci. Rep. 14, 9799. https:\/\/doi.org\/10.1038\/s41598-024-58877-z (2024).","journal-title":"Sci. Rep."},{"key":"698_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1290398","author":"NK Jain","year":"2024","unstructured":"Jain, N. K. et al. Integrating network pharmacology with molecular docking to rationalize the ethnomedicinal use of Alchornea laxiflora (Benth.) Pax & K. Hoffm. for efficient treatment of depression. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1290398 (2024).","journal-title":"Front. Pharmacol."},{"key":"698_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108195","volume":"172","author":"DSN Sasikumar","year":"2024","unstructured":"Sasikumar, D. S. N. et al. Insights into dietary phytochemicals targeting Parkinson\u2019s disease key genes and pathways: A network pharmacology approach. Comput. Biol. Med. 172, 108195. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108195 (2024).","journal-title":"Comput. Biol. Med."},{"key":"698_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10658-y","author":"GA Gyebi","year":"2023","unstructured":"Gyebi, G. A. et al. Identification of potential inhibitors of cholinergic and \u03b2-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: An integrated computational analysis. Mol. Diversity https:\/\/doi.org\/10.1007\/s11030-023-10658-y (2023).","journal-title":"Mol. Diversity"},{"key":"698_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10397-6","author":"OM Ogunyemi","year":"2022","unstructured":"Ogunyemi, O. M. et al. Identification of promising multi-targeting inhibitors of obesity from Vernonia amygdalina through computational analysis. Mol. Diversity https:\/\/doi.org\/10.1007\/s11030-022-10397-6 (2022).","journal-title":"Mol. Diversity"},{"key":"698_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01467-7","author":"GA Gyebi","year":"2024","unstructured":"Gyebi, G. A. et al. Cholinergic inhibition and antioxidant potential of Gongronema latifolium benth leaf in neurodegeneration: Experimental and in silico study. Cell Biochem. Biophys. https:\/\/doi.org\/10.1007\/s12013-024-01467-7 (2024).","journal-title":"Cell Biochem. Biophys."},{"key":"698_CR29","doi-asserted-by":"publisher","first-page":"4758189","DOI":"10.1155\/2022\/4758189","volume":"2022","author":"Z Shen","year":"2022","unstructured":"Shen, Z. & Yu, M. Network pharmacology and molecular docking analyses unveil the mechanisms of Yiguanjian decoction against Parkinson\u2019s disease from inner\/outer brain perspective. BioMed Res. Int. 2022, 4758189. https:\/\/doi.org\/10.1155\/2022\/4758189 (2022).","journal-title":"BioMed Res. Int."},{"key":"698_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34113","author":"A Sun","year":"2024","unstructured":"Sun, A., Li, Y.-F., Miao, Y., Wang, H.-X. & Zhang, L.-L. Research on the mechanism of Ursolic acid for treating Parkinson\u2019s disease by network pharmacology and experimental verification. Heliyon https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34113 (2024).","journal-title":"Heliyon"},{"key":"698_CR31","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/nu11050946","volume":"11","author":"L Malaguarnera","year":"2019","unstructured":"Malaguarnera, L. Influence of resveratrol on the immune response. Nutrients 11, 946 (2019).","journal-title":"Nutrients"},{"key":"698_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.abb.2018.02.011","volume":"643","author":"J Suh","year":"2018","unstructured":"Suh, J., Kim, D.-H. & Surh, Y.-J. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch. Biochem. Biophys. 643, 62\u201371 (2018).","journal-title":"Arch. Biochem. Biophys."},{"key":"698_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroscience.2017.02.027","volume":"348","author":"H Zhao","year":"2017","unstructured":"Zhao, H. et al. Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1\/AMPK signaling pathway. Neuroscience 348, 241\u2013251 (2017).","journal-title":"Neuroscience"},{"key":"698_CR34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/molecules22091529","volume":"22","author":"X-L Wang","year":"2017","unstructured":"Wang, X.-L., Li, T., Li, J.-H., Miao, S.-Y. & Xiao, X.-Z. The effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease. Molecules 22, 1529 (2017).","journal-title":"Molecules"},{"key":"698_CR35","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3389\/fphar.2018.01261","volume":"9","author":"S Andrade","year":"2018","unstructured":"Andrade, S., Ramalho, M. J., Pereira, M. D. C. & Loureiro, J. A. Resveratrol brain delivery for neurological disorders prevention and treatment. Front. Pharmacol. 9, 1261 (2018).","journal-title":"Front. Pharmacol."},{"key":"698_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.bbrc.2018.06.114","volume":"503","author":"AO Abolaji","year":"2018","unstructured":"Abolaji, A. O., Adedara, A. O., Adie, M. A., Vicente-Crespo, M. & Farombi, E. O. Resveratrol prolongs lifespan and improves 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced oxidative damage and behavioural deficits in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 503, 1042\u20131048 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"698_CR37","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1038\/s41598-022-07909-7","volume":"12","author":"AO Adedara","year":"2022","unstructured":"Adedara, A. O. et al. An assessment of the rescue action of resveratrol in parkin loss of function-induced oxidative stress in Drosophila melanogaster. Sci. Rep. 12, 3922 (2022).","journal-title":"Sci. Rep."},{"key":"698_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","volume":"12","author":"BD Arbo","year":"2020","unstructured":"Arbo, B. D. et al. Resveratrol derivatives as potential treatments for Alzheimer\u2019s and Parkinson\u2019s disease. Front. Aging Neurosci. 12, 103. https:\/\/doi.org\/10.3389\/fnagi.2020.00103 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"698_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644219","volume":"12","author":"CF Su","year":"2021","unstructured":"Su, C. F., Jiang, L., Zhang, X. W., Iyaswamy, A. & Li, M. Resveratrol in rodent models of Parkinson\u2019 disease: A systematic review of experimental studies. Front. Pharmacol. 12, 644219. https:\/\/doi.org\/10.3389\/fphar.2021.644219 (2021).","journal-title":"Front. Pharmacol."},{"key":"698_CR40","doi-asserted-by":"publisher","first-page":"105533","DOI":"10.1016\/j.jff.2023.105533","volume":"104","author":"F Sarubbo","year":"2023","unstructured":"Sarubbo, F. et al. Resveratrol improves episodic-like memory and motor coordination through modulating neuroinflammation in old rats. J. Funct. Foods 104, 105533. https:\/\/doi.org\/10.1016\/j.jff.2023.105533 (2023).","journal-title":"J. Funct. Foods"},{"key":"698_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"C Moussa","year":"2017","unstructured":"Moussa, C. et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J. Neuroinflammation 14, 1\u201310 (2017).","journal-title":"J. Neuroinflammation"},{"key":"698_CR42","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000337","author":"CJ Gimblet","year":"2023","unstructured":"Gimblet, C. J. et al. Effect of resveratrol on endothelial function in patients with CKD and diabetes: A randomized controlled trial. Clin. J. Am. Soc. Nephrol https:\/\/doi.org\/10.2215\/CJN.0000000000000337 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"698_CR43","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/antiox11081623","volume":"11","author":"S Shabir","year":"2022","unstructured":"Shabir, S., Yousuf, S., Singh, S. K., Vamanu, E. & Singh, M. P. Ethnopharmacological effects of Urtica dioica, Matricaria chamomilla, and Murraya koenigii on rotenone-exposed D. melanogaster: An attenuation of cellular, biochemical, and organismal markers. Antioxidants 11, 1623 (2022).","journal-title":"Antioxidants"},{"key":"698_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gene.10150","volume":"34","author":"JB Duffy","year":"2002","unstructured":"Duffy, J. B. GAL4 system in Drosophila: A fly geneticist\u2019s Swiss army knife. Genesis 34, 1\u201315 (2002).","journal-title":"Genesis"},{"key":"698_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41575-020-0339-z","volume":"17","author":"RA Travagli","year":"2020","unstructured":"Travagli, R. A., Browning, K. N. & Camilleri, M. Parkinson disease and the gut: New insights into pathogenesis and clinical relevance. Nat. Rev. Gastroenterol. Hepatol. 17, 673\u2013685 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"698_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111297","volume":"190","author":"SK Soo","year":"2020","unstructured":"Soo, S. K. et al. Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders. Mech. Ageing Dev. 190, 111297 (2020).","journal-title":"Mech. Ageing Dev."},{"key":"698_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111226","volume":"146","author":"CA Caldeira","year":"2021","unstructured":"Caldeira, C. A. et al. Resveratrol: Change of SIRT 1 and AMPK signaling pattern during the aging process. Exp. Gerontol. 146, 111226 (2021).","journal-title":"Exp. Gerontol."},{"key":"698_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","volume":"282","author":"H Wang","year":"2018","unstructured":"Wang, H., Jiang, T., Li, W., Gao, N. & Zhang, T. Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer\u2019s disease. Toxicol. Lett. 282, 100\u2013108 (2018).","journal-title":"Toxicol. Lett."},{"key":"698_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/1871527320666210208125912","volume":"20","author":"F Naz","year":"2021","unstructured":"Naz, F. & Siddique, Y. H. Drosophila melanogaster a versatile model of Parkinson\u2019s disease. CNS Neurol. Disorders-Drug Targets (Former. Curr. Drug Targets CNS Neurol. Disorders) 20, 487\u2013530 (2021).","journal-title":"CNS Neurol. Disorders-Drug Targets (Former. Curr. Drug Targets CNS Neurol. Disorders)"},{"key":"698_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.10.034","volume":"314","author":"SD Hettiarachchi","year":"2019","unstructured":"Hettiarachchi, S. D. et al. Nanoparticle-mediated approaches for Alzheimer\u2019s disease pathogenesis, diagnosis, and therapeutics. J. Control. Release 314, 125\u2013140 (2019).","journal-title":"J. Control. Release"},{"key":"698_CR51","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.3390\/molecules171011391","volume":"17","author":"S Koppula","year":"2012","unstructured":"Koppula, S. et al. Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson\u2019s disease. Molecules 17, 11391\u201311420 (2012).","journal-title":"Molecules"},{"key":"698_CR52","first-page":"588","volume":"42","author":"A Ibrahim","year":"2023","unstructured":"Ibrahim, A. & Muhammad, S. A. Antioxidant-rich nutraceutical as a therapeutic strategy for sickle cell disease. J. Am. Nutr. Assoc. 42, 588\u2013597 (2023).","journal-title":"J. Am. Nutr. Assoc."},{"key":"698_CR53","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3390\/ijms20102407","volume":"20","author":"F Collin","year":"2019","unstructured":"Collin, F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int. J. Mol. Sci. 20, 2407 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"698_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbd.2015.04.020","volume":"84","author":"CA Cobb","year":"2015","unstructured":"Cobb, C. A. & Cole, M. P. Oxidative and nitrative stress in neurodegeneration. Neurobiol. Dis. 84, 4\u201321 (2015).","journal-title":"Neurobiol. Dis."},{"key":"698_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ygcen.2018.09.008","volume":"279","author":"P Nath","year":"2019","unstructured":"Nath, P. & Maitra, S. Physiological relevance of nitric oxide in ovarian functions: An overview. Gen. Comp. Endocrinol. 279, 35\u201344 (2019).","journal-title":"Gen. Comp. Endocrinol."},{"key":"698_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2015.03.017","volume":"84","author":"T Nakamura","year":"2015","unstructured":"Nakamura, T. et al. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases. Neurobiol. Dis. 84, 99\u2013108 (2015).","journal-title":"Neurobiol. Dis."},{"key":"698_CR57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher, P., Beckman, J. S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315\u2013424 (2007).","journal-title":"Physiol. Rev."},{"key":"698_CR58","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1021\/ja5131726","volume":"137","author":"R Burai","year":"2015","unstructured":"Burai, R., Ait-Bouziad, N., Chiki, A. & Lashuel, H. A. Elucidating the role of site-specific nitration of \u03b1-synuclein in the pathogenesis of Parkinson\u2019s disease via protein semisynthesis and mutagenesis. J. Am. Chem. Soc. 137, 5041\u20135052 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"698_CR59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cbi.2017.11.018","volume":"279","author":"MR Poetini","year":"2018","unstructured":"Poetini, M. R. et al. Hesperidin attenuates iron-induced oxidative damage and dopamine depletion in Drosophila melanogaster model of Parkinson\u2019s disease. Chem. Biol. Interact. 279, 177\u2013186 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"698_CR60","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2014.08.017","volume":"80","author":"CC Winterbourn","year":"2015","unstructured":"Winterbourn, C. C. Are free radicals involved in thiol-based redox signaling?. Free Radical Biol. Med. 80, 164\u2013170 (2015).","journal-title":"Free Radical Biol. Med."},{"key":"698_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-5793(03)00081-4","volume":"537","author":"SR Paik","year":"2003","unstructured":"Paik, S. R., Lee, D., Cho, H.-J., Lee, E.-N. & Chang, C.-S. Oxidized glutathione stimulated the amyloid formation of \u03b1-synuclein. FEBS Lett. 537, 63\u201367 (2003).","journal-title":"FEBS Lett."},{"key":"698_CR62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume-title":"Oxygen Radicals in Biological Systems","author":"H Aebi","year":"1984","unstructured":"Aebi, H. Catalase in vitro. In Oxygen Radicals in Biological Systems 121\u2013126 (Elsevier, 1984)."},{"key":"698_CR63","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/s41598-018-29770-3","volume":"8","author":"P Youssef","year":"2018","unstructured":"Youssef, P. et al. Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer\u2019s disease. Sci. Rep. 8, 11553 (2018).","journal-title":"Sci. Rep."},{"key":"698_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","volume":"32","author":"LM Ambani","year":"1975","unstructured":"Ambani, L. M., Van Woert, M. H. & Murphy, S. Brain peroxidase and catalase in Parkinson disease. Arch. Neurol. 32, 114\u2013118 (1975).","journal-title":"Arch. Neurol."},{"key":"698_CR65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbadis.2011.11.003","volume":"1822","author":"A Bulteau","year":"2012","unstructured":"Bulteau, A. et al. Changes in mitochondrial glutathione levels and protein thiol oxidation in\u2206 yfh1 yeast cells and the lymphoblasts of patients with Friedreich\u2019s ataxia. Biochim. Biophys. Acta BBA-Mol. Basis Disease 1822, 212\u2013225 (2012).","journal-title":"Biochim. Biophys. Acta BBA-Mol. Basis Disease"},{"key":"698_CR66","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1172\/JCI130351","volume":"129","author":"KC Luk","year":"2019","unstructured":"Luk, K. C. Oxidative stress and \u03b1-synuclein conspire in vulnerable neurons to promote Parkinson\u2019s disease progression. J. Clin. Investig. 129, 3530\u20133531 (2019).","journal-title":"J. Clin. Investig."},{"key":"698_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1245049","author":"S Di Meo","year":"2016","unstructured":"Di Meo, S., Reed, T. T., Venditti, P. & Victor, V. M. Role of ROS and RNS sources in physiological and pathological conditions. Oxid. Med. Cell. Longev. https:\/\/doi.org\/10.1155\/2016\/1245049 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"698_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"T Jiang","year":"2016","unstructured":"Jiang, T., Sun, Q. & Chen, S. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog. Neurobiol. 147, 1\u201319 (2016).","journal-title":"Prog. Neurobiol."},{"key":"698_CR69","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jcph.1575","volume":"60","author":"AG Sathe","year":"2020","unstructured":"Sathe, A. G. et al. Pharmacokinetics, safety, and tolerability of orally administered ursodeoxycholic acid in patients with Parkinson\u2019s disease\u2014A pilot study. J. Clin. Pharmacol. 60, 744\u2013750 (2020).","journal-title":"J. Clin. Pharmacol."},{"key":"698_CR70","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.1002\/jcb.28339","volume":"120","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. GDF-15 promotes mitochondrial function and proliferation in neuronal HT22 cells. J. Cell. Biochem. 120, 10530\u201310547 (2019).","journal-title":"J. Cell. Biochem."},{"key":"698_CR71","first-page":"22","volume":"119","author":"L Li","year":"2018","unstructured":"Li, L., Xu, J., Wu, M. & Hu, J. Protective role of microRNA-221 in Parkinson\u2019s disease. Bratisl. Lek. Listy 119, 22\u201327 (2018).","journal-title":"Bratisl. Lek. Listy"},{"key":"698_CR72","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1471-4159.2005.03587.x","volume":"96","author":"AP Signore","year":"2006","unstructured":"Signore, A. P. et al. Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. J. Neurochem. 96, 428\u2013443 (2006).","journal-title":"J. Neurochem."},{"key":"698_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115496","volume":"210","author":"S Samim Khan","year":"2023","unstructured":"Samim Khan, S. et al. GSK-3\u03b2: An exuberating neuroinflammatory mediator in Parkinson\u2019s disease. Biochem. Pharmacol. 210, 115496. https:\/\/doi.org\/10.1016\/j.bcp.2023.115496 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"698_CR74","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti, E., Dincer, O. & Pratic\u00f2, D. Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim. Biophys. Acta BBA Mol. Cell Res. 1867, 118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664 (2020).","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"698_CR75","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1007\/s12035-024-04003-z","volume":"61","author":"A Turkistani","year":"2024","unstructured":"Turkistani, A. et al. Therapeutic potential effect of glycogen synthase kinase 3 beta (GSK-3\u03b2) inhibitors in parkinson disease: Exploring an overlooked avenue. Mol. Neurobiol. 61, 7092\u20137108. https:\/\/doi.org\/10.1007\/s12035-024-04003-z (2024).","journal-title":"Mol. Neurobiol."},{"key":"698_CR76","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/brain\/awx172","volume":"140","author":"J Tong","year":"2017","unstructured":"Tong, J. et al. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain J. Neurol. 140, 2460\u20132474. https:\/\/doi.org\/10.1093\/brain\/awx172 (2017).","journal-title":"Brain J. Neurol."},{"key":"698_CR77","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/jpd-212976","volume":"12","author":"YY Tan","year":"2022","unstructured":"Tan, Y. Y., Jenner, P. & Chen, S. D. Monoamine oxidase-B Inhibitors for the treatment of Parkinson\u2019s disease: Past, present, and future. J. Parkinsons Dis. 12, 477\u2013493. https:\/\/doi.org\/10.3233\/jpd-212976 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"698_CR78","doi-asserted-by":"publisher","first-page":"308","DOI":"10.37349\/ent.2024.00085","volume":"4","author":"PK Chandra Sekar","year":"2024","unstructured":"Chandra Sekar, P. K., Thomas, S. M. & Veerabathiran, R. An overview of the role of monoamine oxidase-B in Parkinson\u2019s disease: Implications for neurodegeneration and therapy. Explor. Neuroprotective Ther. 4, 308\u2013318. https:\/\/doi.org\/10.37349\/ent.2024.00085 (2024).","journal-title":"Explor. Neuroprotective Ther."},{"key":"698_CR79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/1389200222666210729115151","volume":"22","author":"A Shah","year":"2021","unstructured":"Shah, A., Ong, C. E. & Pan, Y. Unveiling the role of cytochrome P450 (2E1) in human brain specifically in Parkinson\u2019s disease - Literature review. Curr. Drug Metab. 22, 698\u2013708. https:\/\/doi.org\/10.2174\/1389200222666210729115151 (2021).","journal-title":"Curr. Drug Metab."},{"key":"698_CR80","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha, E. M., De Miranda, B. & Sanders, L. H. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol. Dis. 109, 249\u2013257. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.004 (2018).","journal-title":"Neurobiol. Dis."},{"key":"698_CR81","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 14, 176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9 (2023).","journal-title":"Cell Death Dis."},{"key":"698_CR82","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nchembio.1246","volume":"9","author":"G Lessene","year":"2013","unstructured":"Lessene, G. et al. Structure-guided design of a selective BCL-X(L) inhibitor. Nat. Chem. Biol. 9, 390\u2013397. https:\/\/doi.org\/10.1038\/nchembio.1246 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"698_CR83","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar, P. E. & Garcia-Saez, A. J. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat. Rev. Mol. Cell Biol. 24, 732\u2013748. https:\/\/doi.org\/10.1038\/s41580-023-00629-4 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"698_CR84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fnmol.2020.00081","volume":"13","author":"J Li","year":"2020","unstructured":"Li, J. et al. GSK-3\u03b2 contributes to Parkinsonian dopaminergic neuron death: Evidence from conditional knockout mice and tideglusib. Front. Mol. Neurosci. 13, 81. https:\/\/doi.org\/10.3389\/fnmol.2020.00081 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"698_CR85","doi-asserted-by":"publisher","first-page":"4209475","DOI":"10.1155\/2019\/4209475","volume":"2019","author":"T Jaworski","year":"2019","unstructured":"Jaworski, T., Banach-Kasper, E. & Gralec, K. GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration. Neural Plast. 2019, 4209475. https:\/\/doi.org\/10.1155\/2019\/4209475 (2019).","journal-title":"Neural Plast."},{"key":"698_CR86","doi-asserted-by":"publisher","unstructured":"Li, J., Huang, Y., Wang, D., Zhu, N. & Qiao, X. Comparison of toxic effects of 5 macrofungi against Drosophila melanogaster. J. Insect Sci. 23(3), 20. https:\/\/doi.org\/10.1093\/jisesa\/iead042 (2023).","DOI":"10.1093\/jisesa\/iead042"},{"key":"698_CR87","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.parkreldis.2013.10.017","volume":"20","author":"D Devos","year":"2014","unstructured":"Devos, D. et al. Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 20, 170\u2013175. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.10.017 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"698_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2023.100212","volume":"9","author":"SH Isaacson","year":"2023","unstructured":"Isaacson, S. H., Hauser, R. A., Pahwa, R., Gray, D. & Duvvuri, S. Dopamine agonists in Parkinson\u2019s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment. Clin. Parkinsonism Relat. Disorders 9, 100212. https:\/\/doi.org\/10.1016\/j.prdoa.2023.100212 (2023).","journal-title":"Clin. Parkinsonism Relat. Disorders"},{"key":"698_CR89","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","volume":"22","author":"JJ Credle","year":"2015","unstructured":"Credle, J. J. et al. GSK-3\u03b2 dysregulation contributes to parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein. Cell Death Differ. 22, 838\u2013851. https:\/\/doi.org\/10.1038\/cdd.2014.179 (2015).","journal-title":"Cell Death Differ."},{"key":"698_CR90","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3892\/mmr.2019.10528","volume":"20","author":"L Yuan","year":"2019","unstructured":"Yuan, L. et al. Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT\/GSK-3\u03b2\/Snail signaling pathway. Mol. Med. Rep. 20, 2783\u20132795. https:\/\/doi.org\/10.3892\/mmr.2019.10528 (2019).","journal-title":"Mol. Med. Rep."},{"key":"698_CR91","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.comtox.2022.100235","volume":"23","author":"DA Omoboyowa","year":"2022","unstructured":"Omoboyowa, D. A. et al. Inhibitory potential of phytochemicals from Chromolaena odorata L. against apoptosis signal-regulatory kinase 1: A computational model against colorectal cancer. Comput. Toxicol. 23, 100235 (2022).","journal-title":"Comput. Toxicol."},{"key":"698_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9258578","volume":"2016","author":"CM Nisha","year":"2016","unstructured":"Nisha, C. M. et al. Molecular docking and in silico ADMET study reveals acylguanidine 7a as a potential inhibitor of \u03b2-secretase. Adv. Bioinform. 2016, 1\u20136. https:\/\/doi.org\/10.1155\/2016\/9258578 (2016).","journal-title":"Adv. Bioinform."},{"key":"698_CR93","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1002\/anie.201603797","volume":"55","author":"SH Liang","year":"2016","unstructured":"Liang, S. H. et al. Discovery of a highly selective glycogen synthase kinase-3 inhibitor (PF-04802367) that modulates tau phosphorylation in the brain: Translation for PET neuroimaging. Angew. Chem. Int. Ed. 55, 9601\u20139605. https:\/\/doi.org\/10.1002\/anie.201603797 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"698_CR94","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7150\/thno.14334","volume":"6","author":"MK Pandey","year":"2016","unstructured":"Pandey, M. K. & DeGrado, T. R. Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging. Theranostics 6, 571\u2013593. https:\/\/doi.org\/10.7150\/thno.14334 (2016).","journal-title":"Theranostics"},{"key":"698_CR95","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.1080\/07391102.2021.1975570","volume":"40","author":"TA Balogun","year":"2022","unstructured":"Balogun, T. A. et al. Discovery of potential HER2 inhibitors from Mangifera indica for the treatment of HER2-positive breast cancer: An integrated computational approach. J. Biomol. Struct. Dyn. 40, 12772\u201312784 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"698_CR96","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1080\/07391102.2022.2091657","volume":"41","author":"DA Omoboyowa","year":"2023","unstructured":"Omoboyowa, D. A., Singh, G., Fatoki, J. O. & Oyeneyin, O. E. Computational investigation of phytochemicals from Abrus precatorius seeds as modulators of peroxisome proliferator-activated receptor gamma (PPAR\u03b3). J. Biomol. Struct. Dyn. 41, 5568\u20135582 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"20","key":"698_CR97","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1080\/07391102.2023.2260491","volume":"42","author":"OE Oyeneyin","year":"2023","unstructured":"Oyeneyin, O. E., Ibrahim, A., Ipinloju, N., Ademoyegun, A. J. & Ojo, N. D. Insight into the corrosion inhibiting potential and anticancer activity of 1-(4-methoxyphenyl)-5-methyl-N\u2019-(2-oxoindolin-3-ylidene)-1H-1,2,3-triazole-4-carbohydrazide via computational approaches. J. Biomol. Struct. Dyn. 42(20), 11149\u201311166. https:\/\/doi.org\/10.1080\/07391102.2023.2260491 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"698_CR98","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"698_CR99","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Andres, V. Jr. & Feather-Stone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9 (1961).","journal-title":"Biochem. Pharmacol."},{"key":"698_CR100","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0076-6879(94)33021-2","volume-title":"Oxygen Radicals in Biological Systems Part C","author":"SP Wolff","year":"1994","unstructured":"Wolff, S. P. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. In Oxygen Radicals in Biological Systems Part C 182\u2013189 (Elsevier, 1994)."},{"key":"698_CR101","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70\u201377 (1959).","journal-title":"Arch. Biochem. Biophys."},{"key":"698_CR102","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green, L. C. et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 126, 131\u2013138 (1982).","journal-title":"Anal. Biochem."},{"key":"698_CR103","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000136485","volume":"11","author":"D Jollow","year":"1974","unstructured":"Jollow, D., Mitchell, J., Zampaglione, N. A. & Gillette, J. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11, 151\u2013169 (1974).","journal-title":"Pharmacology"},{"key":"698_CR104","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351\u2013358 (1979).","journal-title":"Anal. Biochem."},{"key":"698_CR105","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0168-0102(00)00188-7","volume":"38","author":"K Abe","year":"2000","unstructured":"Abe, K. & Matsuki, N. Measurement of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci. Res. 38, 325\u2013329 (2000).","journal-title":"Neurosci. Res."},{"key":"698_CR106","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.redox.2015.06.001","volume":"5","author":"AO Abolaji","year":"2015","unstructured":"Abolaji, A. O. et al. Ovotoxicants 4-vinylcyclohexene 1, 2-monoepoxide and 4-vinylcyclohexene diepoxide disrupt redox status and modify different electrophile sensitive target enzymes and genes in Drosophila melanogaster. Redox Biol. 5, 328\u2013339 (2015).","journal-title":"Redox Biol."},{"issue":"D1","key":"698_CR107","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: Protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucl. Acids Res. 51(D1), D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucl. Acids Res."},{"key":"698_CR108","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res."},{"key":"698_CR109","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin, C.-H. et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"698_CR110","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931 (2020).","journal-title":"Bioinformatics"},{"key":"698_CR111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: An open chemical toolbox. J. Cheminformatics 3, 33. https:\/\/doi.org\/10.1186\/1758-2946-3-33 (2011).","journal-title":"J. Cheminformatics"},{"key":"698_CR112","doi-asserted-by":"publisher","DOI":"10.1093\/bioadv\/vbad133","author":"JA Adetunji","year":"2023","unstructured":"Adetunji, J. A., Ogunyemi, O. M., Gyebi, G. A., Adewumi, A. E. & Olaiya, C. O. Atomistic simulations suggest dietary flavonoids from Beta vulgaris (beet) as promising inhibitors of human angiotensin-converting enzyme and 2-alpha-adrenergic receptors in hypertension. Bioinf. Adv. https:\/\/doi.org\/10.1093\/bioadv\/vbad133 (2023).","journal-title":"Bioinf. Adv."},{"key":"698_CR113","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281\u2013296 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"698_CR114","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s42250-022-00373-w","volume":"5","author":"DA Omoboyowa","year":"2022","unstructured":"Omoboyowa, D. A. Virtual screening of phyto-compounds from Blighia sapida as protein tyrosine phosphatase 1B inhibitor: A computational approach against diabetes. Chem. Afr. 5, 871\u2013881 (2022).","journal-title":"Chem. Afr."},{"key":"698_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-021-00658-z","volume":"45","author":"DA Omoboyowa","year":"2021","unstructured":"Omoboyowa, D. A. Sterols from Jatropha tanjorensis leaves exhibit anti-inflammatory potential: In vitro and in silico studies. Bull. Natl. Res. Centre 45, 1\u201313 (2021).","journal-title":"Bull. Natl. Res. Centre"},{"key":"698_CR116","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s42250-021-00304-1","volume":"5","author":"OE Oyeneyin","year":"2022","unstructured":"Oyeneyin, O. E., Ojo, N. D., Ipinloju, N., James, A. C. & Agbaffa, E. B. Investigation of corrosion inhibition potentials of some aminopyridine schiff bases using density functional theory and Monte Carlo simulation. Chem. Afr. 5, 319\u2013332 (2022).","journal-title":"Chem. Afr."},{"key":"698_CR117","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1063\/1.462066","volume":"96","author":"AD Becke","year":"1992","unstructured":"Becke, A. D. Density-functional thermochemistry. I. The effect of the exchange-only gradient correction. J. Chem. Phys. 96, 2155\u20132160 (1992).","journal-title":"J. Chem. Phys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00698-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T06:05:17Z","timestamp":1747893917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00698-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17769"}}